COVID Update: Masks are still required in health care settings, even if you’re fully vaccinated. Also, Scripps does not provide COVID-19 tests for asymptomatic patients. See FAQs.

Reduction of Recurrent Stroke in Patients with Patent Foramen Ovale (PFO)

Trial ID:
IRB-21-7777
Matthew J Price, M.D.
This study will look at closing the PFO to reduce the risk of another stroke using a commercial market-approved medical device called a septal occluder.

Inclusion Criteria

Patients must:
  • Be 18-70 years of age
  • Have been diagnosed with an ischemic stroke within the last 455 days
  • Have the presence of a PFO
  • Be willing and able to comply with protocol requirements, including follow-up visits

Exclusion Criteria

Patients must not:
  • Have a history of, or ongoing, atrial fibrillation/flutter
  • Have had a previous heart attack

Additional Info

  • All treatments and physician visits during this study will take place at Scripps Memorial Hospital, Anderson Medical Pavilion in La Jolla.
  • Search for NCT03821129 at www.clinicaltrials.gov for more information.
  • Study participation will last up to 5 years.

Contact Info:

  • Clinical Research Services
  • CRSLeadership@scrippshealth.org